UNSPSC 51282329: Erythromycin thiocyanate

This classification denotes a macrolide antibiotic C37H67NO13.CHNS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y7A95YRI88, chemically known as thiocyanic acid, compd. with erythromycin (1:1), but more generally known as erythromycin thiocyanate, which bears US NIH Compound Identifier 83938. Most nations, for tariff and trade purposes, schedule erythromycin thiocyanate under HS 29415000 and SITC 54139. As of Q4 2014, ERYTHROMYCIN THIOCYANATE remains US FDA's Preferred Term for this commodity.

SMILES: CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O.C(#N)S.

UNSPSC 51282329 Erythromycin thiocyanate is a Commodity code that appears in state and local procurement records with limited recent relevance. The code's nominal scope—a specific antibiotic agent—does not align with the recent contract opportunities posted under it. The Illinois Department of Public Health awarded a pharmaceutical piggyback contract through the MMCAP cooperative purchasing vehicle to Chartwell Rx LLC for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets, neither of which is erythromycin thiocyanate. A second record—Seminole County, Florida's IFB for Naloxone and Safe Drug Deactivation Systems—similarly mismatches the code's pharmaceutical scope. These opportunities reflect state health departments and county health agencies buying pharmaceuticals and medical supplies through cooperative purchasing and competitive bidding, but the specific products do not correspond to erythromycin thiocyanate procurement.

Geographic activity is limited to Illinois and Florida in the recent record, and both posted opportunities appear to be either completed awards or misclassified tags. No active open solicitations for erythromycin thiocyanate itself are present in the source. Firms monitoring this code should verify with issuing bodies whether erythromycin thiocyanate demand exists within their jurisdictions, as the current tag activity suggests either sparse genuine procurement under this specific antibiotic or systematic miscoding of pharmaceutical supplies in the state and local system.